Clinical and Molecular Hepatology10.3350/cmh.2023.00942023292345-348The prime time for management of hepatocellular carcinoma in Hong KongLandon L. Chan, Stephen L. Chan,,
Hong Kong Journal of Radiology10.12809/hkjr17169212017Update on Positron Emission Tomography for Hepatocellular Carcinoma
Hong Kong Journal of Radiology10.12809/hkjr17153772017Ultrasound-guided Radiofrequency Ablation for Early Hepatocellular Carcinoma
Hong Kong Journal of Radiology10.12809/hkjr17164362017Splenic Metastasis of Hepatocellular Carcinoma with Spleen Rupture
Hong Kong Journal of Radiology10.12809/hkjr17169052017Selective Internal Radiation Therapy for Hepatocellular Carcinoma: Experience from a Hospital in Hong Kong
Hong Kong Journal of Radiology10.12809/hkjr17168602017Cone-beam Computed Tomography for Transarterial Radioembolisation or Chemoembolisation of Hepatocellular Carcinoma
Hong Kong Journal of Radiology10.12809/hkjr17169022017Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Review of a Local Hospital
Hong Kong Journal of Radiology10.12809/hkjr17168712017Gadoxetic Acid–enhanced Magnetic Resonance Imaging and Contrast-enhanced Ultrasonography in the Diagnosis of Hepatocellular Carcinoma
Clinica Chimica Acta10.1016/j.cca.2015.03.0312015445161-166Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?Martina Montagnana, Elisa Danese, Giuseppe Lippi,
Gastroenterology10.1053/j.gastro.2020.12.013202116041423-1424Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?Andrea Casadei-Gardini, Stefano Cascinu, Massimo Colombo,